JP2025172864A5 - - Google Patents
Info
- Publication number
- JP2025172864A5 JP2025172864A5 JP2025141835A JP2025141835A JP2025172864A5 JP 2025172864 A5 JP2025172864 A5 JP 2025172864A5 JP 2025141835 A JP2025141835 A JP 2025141835A JP 2025141835 A JP2025141835 A JP 2025141835A JP 2025172864 A5 JP2025172864 A5 JP 2025172864A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- pharmaceutically acceptable
- acceptable salt
- gip
- gip analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2019/083506 WO2020115048A1 (en) | 2018-12-03 | 2019-12-03 | Modified gip peptide analogues |
| EPPCT/EP2019/083506 | 2019-12-03 | ||
| EP20179259.5 | 2020-06-10 | ||
| EP20179259 | 2020-06-10 | ||
| PCT/EP2020/084487 WO2021110845A1 (en) | 2019-12-03 | 2020-12-03 | Optimized gip peptide analogues |
| JP2022532697A JP7788376B2 (ja) | 2019-12-03 | 2020-12-03 | 最適化されたｇｉｐペプチド類縁体 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022532697A Division JP7788376B2 (ja) | 2019-12-03 | 2020-12-03 | 最適化されたｇｉｐペプチド類縁体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025172864A JP2025172864A (ja) | 2025-11-26 |
| JP2025172864A5 true JP2025172864A5 (https=) | 2026-03-16 |
Family
ID=71083547
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022532697A Active JP7788376B2 (ja) | 2019-12-03 | 2020-12-03 | 最適化されたｇｉｐペプチド類縁体 |
| JP2025141835A Pending JP2025172864A (ja) | 2019-12-03 | 2025-08-28 | 最適化されたｇｉｐペプチド類縁体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022532697A Active JP7788376B2 (ja) | 2019-12-03 | 2020-12-03 | 最適化されたｇｉｐペプチド類縁体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250346647A2 (https=) |
| EP (1) | EP4069719A1 (https=) |
| JP (2) | JP7788376B2 (https=) |
| KR (1) | KR20220108064A (https=) |
| CN (1) | CN114761420B (https=) |
| AU (1) | AU2020398675A1 (https=) |
| CA (1) | CA3157387A1 (https=) |
| IL (1) | IL293249A (https=) |
| MX (1) | MX2022006737A (https=) |
| WO (1) | WO2021110845A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3221661A1 (en) * | 2021-06-10 | 2022-12-15 | Alexander HOVARD SPARRE-ULRICH | Treatment of obesity and obesity-related disorders |
| WO2023139106A2 (en) * | 2022-01-18 | 2023-07-27 | Novo Nordisk A/S | Long-acting gipr antagonists |
| EP4556487A1 (en) * | 2022-07-13 | 2025-05-21 | Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. | Glp-1/gip dual agonist, and preparation method therefor and use thereof |
| TW202529796A (zh) * | 2023-11-22 | 2025-08-01 | 大陸商杭州中美華東製藥有限公司 | Glp-1r/gipr雙標靶激動劑在製備動物藥的用途 |
| WO2025259957A1 (en) * | 2024-06-14 | 2025-12-18 | Eli Lilly And Company | Compositions and methods for improving insulin sensitivity |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8263545B2 (en) * | 2005-02-11 | 2012-09-11 | Amylin Pharmaceuticals, Inc. | GIP analog and hybrid polypeptides with selectable properties |
| CN101155828A (zh) * | 2005-02-11 | 2008-04-02 | 安米林药品公司 | Gip类似物和具有可选择性质的杂合多肽 |
| KR20070115947A (ko) * | 2005-02-11 | 2007-12-06 | 아밀린 파마슈티칼스, 인크. | 선택가능한 특성들을 가지는 ｇｉｐ 유사체 및 하이브리드폴리펩타이드 |
| WO2008021560A2 (en) * | 2006-08-17 | 2008-02-21 | Amylin Pharmaceuticals, Inc. | Dpp-iv resistant gip hybrid polypeptides with selectable properties |
| WO2010016940A2 (en) * | 2008-08-07 | 2010-02-11 | Ipsen Pharma S.A.S. | Analogues of glucose-dependent insulinotropic polypeptide |
| ES2574835T3 (es) * | 2008-08-07 | 2016-06-22 | Ipsen Pharma S.A.S. | Análogos del polipéptido insulinotrópico dependiente de glucosa |
| WO2010016936A1 (en) * | 2008-08-07 | 2010-02-11 | Ipsen Pharma S.A.S. | Pharmaceutical compositions of analogues of glucose-dependent insulinotropic polypeptide |
| CN107129538B (zh) * | 2010-04-27 | 2021-07-16 | 西兰制药公司 | Glp-1受体激动剂和胃泌素的肽缀合物及其用途 |
| IN2014MN02304A (https=) * | 2012-05-03 | 2015-08-07 | Zealand Pharma As | |
| ES2685987T3 (es) * | 2014-09-05 | 2018-10-15 | University Of Copenhagen | Análogos de péptidos gip |
| KR102743887B1 (ko) * | 2017-05-31 | 2024-12-19 | 유니버시티 오브 코펜하겐 | 장기-작용성 gip 펩타이드 유사체 |
| AR113486A1 (es) * | 2017-12-21 | 2020-05-06 | Lilly Co Eli | Análogos de incretina y sus usos |
| SG11202105586YA (en) * | 2018-12-03 | 2021-06-29 | Antag Therapeutics Aps | Modified gip peptide analogues |
-
2020
- 2020-12-03 US US17/776,976 patent/US20250346647A2/en active Pending
- 2020-12-03 CN CN202080083881.1A patent/CN114761420B/zh active Active
- 2020-12-03 WO PCT/EP2020/084487 patent/WO2021110845A1/en not_active Ceased
- 2020-12-03 AU AU2020398675A patent/AU2020398675A1/en active Pending
- 2020-12-03 MX MX2022006737A patent/MX2022006737A/es unknown
- 2020-12-03 KR KR1020227018518A patent/KR20220108064A/ko active Pending
- 2020-12-03 IL IL293249A patent/IL293249A/en unknown
- 2020-12-03 CA CA3157387A patent/CA3157387A1/en active Pending
- 2020-12-03 EP EP20815874.1A patent/EP4069719A1/en active Pending
- 2020-12-03 JP JP2022532697A patent/JP7788376B2/ja active Active
-
2025
- 2025-08-28 JP JP2025141835A patent/JP2025172864A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025172864A5 (https=) | ||
| JP2022509568A5 (https=) | ||
| JP7658877B2 (ja) | インクレチン類似体およびその使用 | |
| JP7605747B2 (ja) | 修飾されたｇｉｐペプチド類似体 | |
| JP2023505441A5 (https=) | ||
| JP5524049B2 (ja) | 目的ペプチドの血漿中半減期延長作用を有するペプチド | |
| AU2018338184B2 (en) | Long-acting co-agonists of the glucagon and GLP-1 receptors | |
| JP7443315B2 (ja) | アシル化オキシントモジュリンペプチド類似体 | |
| JP7450724B2 (ja) | インクレチン類似体およびその使用 | |
| TW202233227A (zh) | 腸促胰島素(incretin)類似物及其用途 | |
| AU2012357739A1 (en) | Glucagon analogues | |
| JP2024521398A5 (https=) | ||
| KR20160079875A (ko) | Ｇｉｐ-ｇｌｐ-1 이원 효능제 화합물 및 방법 | |
| JP2012506402A5 (https=) | ||
| TW202241933A (zh) | 多肽及其用途 | |
| CA3222051A1 (en) | Polypeptide derivative having effect of dual targeted activation of glp-1r and gipr, preparation method therefor, and use thereof | |
| JP2021535119A5 (https=) | ||
| JP2020521784A5 (https=) | ||
| JP2020521784A (ja) | 長時間作用性ｇｉｐペプチド類似体 | |
| JP2022507239A (ja) | グルカゴン由来ペプチド及びその用途 | |
| JP2025508820A (ja) | Ｃｒｆ２受容体アゴニスト及び治療法におけるそれらの使用 | |
| CN104364262A (zh) | N末端修饰的胰岛素衍生物 | |
| TW202532095A (zh) | Ｇｉｐ／ｇｌｐ１／ｇｃｇ三受體促效及其用途 | |
| WO1997049724A1 (fr) | Depsipeptides cycliques et medicaments contenant ces composes comme ingredient actif | |
| RU2022116575A (ru) | Оптимизированные пептидные аналоги gip |